CAREDX INC (CDNA) Stock News

USA - NASDAQ:CDNA - US14167L1035 - Common Stock

15.935 USD

+0.07 (+0.41%)

Last: 11/14/2025, 8:00:02 PM

15.93 USD

-0.01 (-0.03%)

After Hours: 11/14/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CDNA Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Chartmill - Mentions: RIGL TREX APPS AXON ...

News Image

What's going on in today's after hours session

5 days ago - By: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

8 days ago - By: CareDx, Inc.

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

9 days ago - By: CareDx, Inc.

CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025

9 days ago - By: Benzinga

3 Analysts Have This To Say About CareDx

10 days ago - By: Zacks Investment Research

CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

10 days ago - By: Zacks Investment Research - Mentions: CODX

CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates

11 days ago - By: CareDx, Inc.

CareDx Announces Third Quarter 2025 Financial Results

11 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

19 days ago - By: CareDx, Inc.

CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer

23 days ago - By: CareDx, Inc.

CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure

24 days ago - By: CareDx, Inc.

CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors

25 days ago - By: CareDx, Inc.

CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

a month ago - By: CareDx, Inc.

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

2 months ago - By: CareDx, Inc.

CareDx Issues Comment Letter on Draft LCD Policy

3 months ago - By: Yahoo Finance

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential

3 months ago - By: Zacks Investment Research

Do Options Traders Know Something About CareDx Stock We Don't?

3 months ago - By: CareDx, Inc.

CareDx to Participate in Wells Fargo Healthcare Conference

3 months ago - By: The Motley Fool

CareDx (CDNA) EPS Beats Sales Gain 14%

3 months ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings

3 months ago - By: Zacks Investment Research - Mentions: ESTA

CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates

3 months ago - By: CareDx, Inc.

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

3 months ago - By: CareDx, Inc.

CareDx Announces Second Quarter 2025 Financial Results

3 months ago - By: CareDx, Inc.

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

4 months ago - By: CareDx, Inc.

CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress

4 months ago - By: CareDx, Inc.

CareDx to Report Second Quarter 2025 Financial Results

4 months ago - By: CareDx, Inc.

CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection

5 months ago - By: CareDx, Inc.

CareDx Announces Repurchase of 5% of Outstanding Shares